Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.

[No authors listed]

Ann Intern Med. 2014 Mar 4;160(5):I-34. doi: 10.7326/P14-9007. No abstract available.

PMID:
24737270
2.

N-of-1 (single-patient) trials for statin-related myalgia.

Joy TR, Zou GY, Mahon JL.

Ann Intern Med. 2014 Oct 7;161(7):531-2. doi: 10.7326/L14-5019-2. No abstract available.

PMID:
25285548
3.

N-of-1 (single-patient) trials for statin-related myalgia.

Akinboro O, Williams L, Pomerantz D.

Ann Intern Med. 2014 Oct 7;161(7):531. doi: 10.7326/L14-5019. No abstract available.

PMID:
25285547
4.

N-of-1 (single-patient) trials for statin-related myalgia.

Joy TR, Monjed A, Zou GY, Hegele RA, McDonald CG, Mahon JL.

Ann Intern Med. 2014 Mar 4;160(5):301-10. doi: 10.7326/M13-1921.

PMID:
24737272
5.

Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?

Ikewaki K, Ayaori M.

Circ J. 2011;75(6):1326-7. Epub 2011 Apr 29. No abstract available.

6.

[Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].

Saku K, Zhang B, Noda K.

Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3679-86. Japanese. No abstract available.

PMID:
22338904
7.

Statin, the black box.

Hatem S, Boccara F.

Arch Cardiovasc Dis. 2008 Jun;101(6):377-9. doi: 10.1016/j.acvd.2008.07.001. Epub 2008 Sep 14. No abstract available.

8.

Atorvastatin for stroke prevention.

[No authors listed]

Med Lett Drugs Ther. 2006 Sep 11;48(1243):75-6. No abstract available.

PMID:
16977287
9.

Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.

Wlodarczyk J, Sullivan D, Smith M.

Am J Cardiol. 2008 Dec 15;102(12):1654-62. doi: 10.1016/j.amjcard.2008.08.014. Epub 2008 Sep 20.

PMID:
19064019
10.
11.

Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.

Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M.

Am Heart J. 2004 Jul;148(1):e4.

PMID:
15215813
12.
13.

Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).

Deedwania PC, Gupta M, Stein M, Ycas J, Gold A; IRIS Study Group..

Am J Cardiol. 2007 Jun 1;99(11):1538-43. Epub 2007 Apr 16.

PMID:
17531577
14.

Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report.

de Jong HJ, Meyboom RH, Helle MJ, Klungel OH, Niskanen L, Cohen Tervaert JW.

Ann Intern Med. 2014 Oct 21;161(8):614-5. doi: 10.7326/L14-5020-6. No abstract available.

PMID:
25329212
15.

Reversible dysphasia and statins.

Davies GR.

J Korean Med Sci. 2012 Apr;27(4):458-9. doi: 10.3346/jkms.2012.27.4.458. Epub 2012 Mar 21.

18.

[Efficacy and safety comparison of different statins in elderly patients].

Chen Y, Jiang C, Liu M, Liu F, Fan Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Nov;42(11):910-5. Chinese.

PMID:
25620252
19.

Update on statins.

Mason P.

J Vasc Nurs. 2004 Jun;22(2):49-50. No abstract available.

PMID:
15179417
20.

Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes.

Mori Y, Kuriyama G, Tanaka T, Tajima N.

Endocrine. 2009 Dec;36(3):412-8. doi: 10.1007/s12020-009-9235-6. Epub 2009 Oct 16. No abstract available.

PMID:
19834827

Supplemental Content

Support Center